Navigation Links
Louise McCormick Joins Heska's Board of Directors
Date:1/3/2008

Ms. McCormick is a former Officer of Aetna, Inc.

LOVELAND, Colo., Jan. 2 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) today announced that Ms. Louise McCormick has joined the company's Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

"We pride ourselves on our commitment to excellence in corporate governance, and a Board consisting of high quality, independent Directors is critical to this effort," said Robert Grieve, Heska's Chairman and CEO. "We are pleased Louise McCormick has chosen to join our Board. I am confident we will benefit from her significant experience and talents."

Ms. McCormick's career includes more than 25 years of experience with Aetna in various finance, strategic planning and legal positions. Her accomplishments include directing the turnaround of Aetna's field property/casualty claim operation, the restructuring and re-staffing of a centralized financial reporting function and the revamping of Aetna's corporate planning process. Ms. McCormick is currently an independent Director, chair of the Investment Committee and a member of the Ethics and Corporate Governance Committee of Foresters, a Toronto-based insurance company.

"I am impressed with Heska's commitment to animal health and recent operating performance. I am excited by the prospects for the products the company has recently launched," commented Ms. McCormick. "I am pleased to join this stellar Board and look forward to a continuation of Heska's demonstrated success."

About Heska

Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at http://www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties related to the impact any given Director or Heska's Board of Directors as a whole may ultimately have on Heska's operating results; risks regarding the commercialization and market acceptance of products Heska has introduced recently or may introduce in the future; risks related to using historical results to predict future outcomes; risks regarding Heska's ability to successfully market, sell and distribute its products; competition; uncertainties regarding Heska's reliance on third parties to whom Heska has granted substantial marketing rights to certain of Heska's existing products; risks regarding Heska's reliance on third-party suppliers, which is substantial; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K for the year ended December 31, 2006 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.


'/>"/>
SOURCE Heska Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Adult-Care.Org, After Its Initial Launch on August 28, 2007, in October 2007 Captures Attention of One of the Fastest Growing NASDAQ Companies, McCormick & Schmicks Seafood Restaurants in Marketing Partnership
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Webster-Calhoun Cooperative Telephone Association (WCCTA) has sent out notices ... March 14th at 7:00 pm at the Southeast Valley High School Gymnasium located in Gowrie, ... Service" What do you look for in a company when you purchase a ...
(Date:2/28/2017)... ... 28, 2017 , ... Las Vegas Skin and Cancer Clinic (LVSCC) is proud ... 10, 2017, 4-7 pm PST. For more than six decades, LVSCC has provided the ... Rancho neighborhood, has been renovated to provide medical and cosmetic dermatological products and services. ...
(Date:2/28/2017)... Chicago, IL (PRWEB) , ... February 28, 2017 ... ... on Tuesday, March 7, 2017, from 4:30-5:30 p.m. at the 11th Annual RISE ... Stars, quality management, financial compliance, performance analytics, and engagement strategies. , The discussion ...
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda ... Awakening, is happy to announce her “Spring Rejuvenation in Sedona” personally tailored ... customized retreats offer the winter-weary soul an excellent opportunity to come out of ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Pharmaceuticals, Inc. (Nasdaq: IONS ) today reported ... with pro forma operating income of $25.8 million and ... The Company also reported a GAAP loss from operations ... of significant accomplishments for Ionis, culminating in the U.S. ... very broad label. The approval of SPINRAZA is a ...
(Date:2/28/2017)... , Feb. 28, 2017 Prepacked ... and biotechnology industry, food and beverage industry, ... research institutes, and analytical laboratories. Acceptance of ... in the pipelines of pharma companies are ... prepacked chromatography columns market. Increasing research and ...
(Date:2/28/2017)... , Feb. 27, 2017  Titan Pharmaceuticals, ... for the treatment of select chronic diseases utilizing ... announced that the U.S. Food & Drug Administration ... ropinirole implant Investigational New Drug Application (IND) and ... the clinical study pending submission of the requested ...
Breaking Medicine Technology: